Prior to its inclusion in the Trump administration's Operation Warp Speed scheme for the rapid deployment of Wuhan coronavirus (Covid-19) "vaccines," Moderna agreed to pay the U.S. [.]
The United States government has released the licensing agreement it hammered out with vaccine manufacturer Moderna and it's highly concerning. The ruling class received $400 million in royalties for helping to "sell" the COVID-19 experimental gene therapy shots to the public.
The tenants say the two-increment increase is unfair because it doesn't give them enough time to figure out how they can afford it or to make other arrangements.